Drugs Channel
Topics & Medications
Quicklinks
Related Channels

Afinitor Dosage

When treating certain types of cancer or tumors with Afinitor, the dosage will depend on the condition being treated, how you respond to the medicine, and other factors. This drug is typically taken once a day. You can take it with or without food, but make sure to take Afinitor the same way every time.

An Introduction to Dosing With Afinitor

The dose of Afinitor® (everolimus) your healthcare provider recommends will vary, depending on a number of factors, including:
 
  • The condition being treated
  • How you respond to Afinitor
  • Other medications you are taking
  • Other medical conditions you may have.
 
As is always the case, do not adjust your dosage unless your healthcare provider specifically tells you to do so.
 

Afinitor Dosage for Pancreatic Cancer

The recommended dose of Afinitor for advanced pancreatic neuroendocrine tumor (PNET) is 10 mg once daily. If serious or intolerable side effects occur, the drug may need to be stopped or reduced to 5 mg daily.
 
The recommended dosage for people with mild liver disease is 7.5 mg a day. The dose may be reduced to 5 mg a day if 7.5 mg is not tolerated. The recommended dosage for people with moderate liver disease is 5 mg daily. The dose may be reduced to 2.5 mg a day if 5 mg is not tolerated. People with severe liver disease should be given no more than 2.5 mg of Afinitor a day.
 
Higher or lower amounts may be used in people taking certain medications known to interact with Afinitor (see Afinitor Drug Interactions for more information).
 
The Zen of Cancer Caregiving - Recharge Your Batteries!

Afinitor Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.